Last week saw several significant developments in the fight to end the mail-order abortion drug crisis in the United States.
The crisis began when former President Biden’s Food and Drug Administration (FDA) gutted in-person dispensing requirements for the abortion drug under the guise of COVID relief, leaving pro-life states to reckon with an onslaught of unregulated mail-order abortion drugs. President Trump’s FDA has not reinstated those commonsense in-person dispensing requirements, and the abortion drug is now responsible for over 63% of abortions.
One such pro-life state, Louisiana, took its fight for the unborn directly to the FDA and abortion drug manufacturers. In October 2025, Louisiana Attorney General Liz Murrell sued the FDA, DANCO Laboratories, and GenBioPro for violating Louisiana state law and injuring Rosalie Markezich, a mother who was poisoned by her abusive boyfriend and lost her baby to the abortion drug. Concerned Women for America (CWA) submitted an amicus brief in support of AG Murrell’s case against the FDA and drug manufacturers.
In April, a federal district court ruled that the case could not continue until after the FDA concludes its stalled safety review of the abortion drug, while also noting that Louisiana is likely to succeed in the long term. Louisiana appealed that decision to the Fifth Circuit Court of Appeals, and in early May, the Fifth Circuit ruled in favor of Louisiana and ordered a nationwide pause on the Biden-era mail-order abortion policy.
That miraculous pause only lasted a weekend. The abortion drug manufacturers’ attorneys appealed to the Supreme Court, and on May 14, the justices ruled to allow mail-order abortions to continue while Louisiana’s case continues in the Fifth Circuit Court. Only Justices Alito and Thomas publicly dissented. Justice Alito rightly noted that the mail-order abortion policy violates pro-life states’ Dobbs-granted right to protect unborn life, and Justice Thomas pointed out that shipping the abortion drug via the mail already violates standing U.S. law: the Comstock Act.
Just days before the Supreme Court handed down its decision last week, a staffing shuffle at the FDA began from the very top—former Commissioner Marty Makary resigned from his post after more than a year of propping up the Biden-era mail-order abortion policy and stalling a promised safety review of the abortion drug mifepristone. Deputy Commissioner Kyle Diamantas assumed the role of Acting Director, and CWA prayerfully hopes that he will lead the FDA with courage and conviction to course-correct the agency with respect to the abortion drug.
The Food and Drug Administration, under acting Director Kyle Diamantas’ leadership, should do its duty to protect American women and babies from the abortion drug and rescind the reckless Biden-era mail-order abortion policies by reinstating in-person dispensing requirements. The Biden scheme deserves a place in the ash heap of history, and such a move will allow sovereign pro-life states to protect their unborn babies from the violence of abortion.
But even reinstating the abortion drug is a bare minimum. Babies in pro-abortion states deserve protection, too. The FDA must conclude its promised, long-overdue safety review of the abortion drug and pull the abortion drug from the market for the purpose of abortion—because as long as the abortion drug kills an unborn baby made in the image of God, it is, by definition, not safe.
Last week saw a significant movement in the fight to end abortion by the abortion drug, and the work is far from finished. That fight requires legal and cultural change. Despite claiming they care about healthcare and women’s empowerment, the pro-abortion left is advocating for a COVID-era policy that leaves women alone to self-manage dangerous abortions in their bathrooms, removes medical oversight and screening from a drug that can be fatal if certain conditions like ectopic pregnancy and gestational age are missed, and empowers abusers, traffickers, and criminals to injure and abuse women and girls. The abortion drug is not “safe and effective.” It always kills an unborn baby and too often leaves a mother traumatized or physically harmed. CWA will continue to speak that truth to a culture of death.
Given that 1) the abortion drug accounts for a majority of the loss of unborn life in America, 2) Biden’s mail-order scheme is preventing pro-life states from protecting their unborn citizens (as is their right per Dobbs), 3) the mail-order scheme empowers abusers, traffickers, and criminals to injure and abuse women and girls, and 4) the fact that 11% of women suffer injury after taking the abortion drug, Concerned Women for America (CWA) views mitigating and eliminating the abortion drug as a top priority.
Please join CWA in praying for an end to the abortion drug crisis—both for a swift end to the Biden mail-order abortion scheme and for the abortion drug itself to be removed from the market. Pray for moms and babies as the mail-order abortion crisis continues to devastate our nation, that the abortion drug lawsuit carrying on in the Fifth Circuit Court of Appeals would be argued well and won, and that Acting FDA Commissioner Kyle Diamanatas would enter his new post with boldness and clarity to protect the most vulnerable Americans among us: the unborn.
